Abstract

The syntheses of a class of three haptens derived from the same 4-aza-steroidal skeleton is described. The sequence begins with oxidative cleavage of ring A of commercially available, optically pure lithocholic acid. Insertion of nitrogen at position 4 and stereoselective hydrogenation of the resulting electron-rich enelactam under 600 psi H2 yielded a system analogous to testosterone-5-alpha-reductase inhibitors. Upon exhaustive reduction of this compound with lithium aluminium hydride, a linker for bioconjugation was attached before the N-oxide key functionality is established in ring A. This functional group is believed to be a true transition-state mimic for the electronic nature of initiation of the cationic cyclization of 2,3-epoxy-squalene derivatives. In addition, it also holds promise for eliciting acidic residues as part of a bait-and-switch strategy. Remarkably, both N-oxide epimers obtained from mCPBA oxidation can be separated by column chromatography on a 60mg scale and were used in enantiopure form for separate immunizations. Reliable configurative assignment was carried out by comparison studies with previously characterized and published systems. A catalytic antibody (HA8-25A10) was obtained from the immunization with the hapten bearing an aminoxide oxygen in the beta position. Surprisingly, an inhibition study showed that the isomer with the inverted configuration at the N-oxide bound more strongly to this catalytic antibody.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.